{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:29:25Z","timestamp":1792787365285,"version":"4.5.0"},"reference-count":94,"publisher":"The Korean Society of Pathologists and The Korean Society for Cytopathology","issue":"1","license":[{"start":{"date-parts":[[2021,12,27]],"date-time":"2021-12-27T00:00:00Z","timestamp":1640563200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":["jpatholtm.org"],"crossmark-restriction":true},"short-container-title":["J Pathol Transl Med"],"published-print":{"date-parts":[[2022,1,15]]},"abstract":"<jats:p>Follicular lymphoma (FL) is the most common indolent B-cell lymphoma and originates from germinal center B-cells (centrocytes and centroblasts) of the lymphoid follicle. Tumorigenesis is believed to initiate early in precursor B-cells in the bone marrow (BM) that acquire the t(14;18)(q32;q21). These cells later migrate to lymph nodes to continue their maturation through the germinal center reaction, at which time they acquire additional genetic and epigeneticabnormalities that promote lymphomagenesis. FLs are heterogeneous in terms of their clinicopathologic features. Most FLs are indolent and clinically characterized by peripheral lymphadenopathy with involvement of the spleen, BM, and peripheral blood in a substantial subset of patients, sometimes accompanied by constitutional symptoms and laboratory abnormalities. Diagnosis is established by the histopathologic identification of a B-cell proliferation usually distributed in an at least partially follicular pattern, typically, but not always, in a lymph node biopsy. The B-cell proliferation is biologically of germinal center cell origin, thus shows an expression of germinal center-associated antigens as detected by immunophenotyping. Although many cases of FLs are typical and histopathologic features are straightforward, the biologic and histopathologic variability of FL is wide, and an accurate diagnosis of FL over this disease spectrum requires knowledge of morphologic variants that can mimic other lymphomas, and rarely non-hematologic malignancies, clinically unique variants, and pitfalls in the interpretation of ancillary studies. The overall survival for most patients is prolonged, but relapses are frequent. The treatment landscape in FL now includes the application of immunotherapy and targeted therapy in addition to chemotherapy.<\/jats:p>","DOI":"10.4132\/jptm.2021.09.29","type":"journal-article","created":{"date-parts":[[2021,12,24]],"date-time":"2021-12-24T00:38:15Z","timestamp":1640306295000},"page":"1-15","update-policy":"https:\/\/doi.org\/10.4132\/crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Follicular lymphoma: updates for pathologists"],"prefix":"10.4132","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6412-6943","authenticated-orcid":true,"given":"Mahsa","family":"Khanlari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6214-4152","authenticated-orcid":true,"given":"Jennifer R.","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2611","reference":[{"key":"ref1","first-page":"266","volume-title":"","author":"Jaffe","year":"2017"},{"key":"ref2","first-page":"570","volume-title":"Generalized giant lymph follicle hyperplasia of lymph nodes and spleen; a hitherto undescribed type","author":"Brill","year":"1952"},{"key":"ref3","first-page":"1063","volume-title":"The pathology and nomenclature of Hodgkin's disease","author":"Lukes","year":"1966"},{"key":"ref4","volume-title":"","author":"Lennert","year":"2006"},{"key":"ref5","first-page":"1361","volume-title":"A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group","author":"Harris","year":"1994"},{"key":"ref6","first-page":"717","volume-title":"Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin's Lymphoma Classification Project","author":"Anderson","year":"1998"},{"key":"ref7","first-page":"3909","volume-title":"The Non-Hodgkin's Lymphoma Classification Project","year":"1997"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/b978-0-12-385991-4.00001-5"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1172\/jci72415"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-019-0132-x"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-08-737361"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1501199112"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-09-457283"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2013.085548"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.07721.x"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/ng.419"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2020000115"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/pas.0000000000001780"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12675"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.5045\/br.2014.49.3.148"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25158"},{"key":"ref22","first-page":"205","volume-title":"","author":"Medeiros","year":"2017"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2017.08.024"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0463.2006.apm_424.x"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/88.3.264"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2010.33.4821"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v99.9.3376"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-05-355255"},{"key":"ref29","first-page":"2673","volume-title":"Genetic evolution of in situ follicular neoplasia to aggressive B-cell lymphoma of germinal center subtype","author":"Vogelsberg","year":"2021"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.307"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0178503"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1097\/01.pas.0000173233.29741.38"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2016-0519-rs"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-03-837252"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2007.049825"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-07-168682"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2016.51"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1097-0142(19990401)85"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2013-201520"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1309\/eg2m-yhb9-wefw-7h1r"},{"key":"ref41","first-page":"730","volume-title":"Splenic follicular lymphoma: clinicopathologic characteristics of a series of 32 cases","author":"Mollejo","year":"2009"},{"key":"ref42","first-page":"656","volume-title":"Follicular lymphoma of the spleen: multiparameter analysis of 16 cases","author":"Howard","year":"2009"},{"key":"ref43","first-page":"321","volume-title":"","author":"Ferry","year":"2017"},{"key":"ref44","first-page":"491","volume-title":"Diagnostic uility of the germinal center-associated markers GCET1, HGAL, and LMO2 in hematolymphoid neoplasms","author":"Menter","year":"2015"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1096-9896(199606)179"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1111\/his.12076"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v101.3.1149"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403738"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020002944"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2014.06.005"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/111.4.488"},{"key":"ref52","first-page":"912","volume-title":"CD5+ follicle center lymphoma. Immunophenotyping detects a unique subset of \u201cfloral\u201d follicular lymphoma","author":"Tiesinga","year":"2000"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1002\/path.1478"},{"key":"ref54","first-page":"1490","volume-title":"Low histologic grade follicular lymphoma with high proliferation index: morphologic and clinical features","author":"Wang","year":"2005"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.10314"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2007.09.010"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.330"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2021.04.014"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12734"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2013.12.027"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(18)30102-5"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v91.12.4677.412k40_4677_4685"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-05-500595"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404479"},{"key":"ref65","first-page":"81","volume-title":"Immunoglobulin heavy chain gene analysis in lymphomas: a multi-center study demonstrating the heterogeneity of performance of polymerase chain reaction assays","author":"Bagg","year":"2002"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2012.176"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.20477"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.21756"},{"key":"ref69","first-page":"406","volume-title":"CD45-negative follicular lymphoma: a rare diagnostic pitfall of a common entity","author":"Khanlari","year":"2021"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13123021"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2020.1855347"},{"key":"ref72","first-page":"337","volume-title":"IRTA1 and MNDA expression in marginal zone lymphoma: utility in differential diagnosis and implications for classification","author":"Wang","year":"2019"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15149"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2014.59.7534"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1200\/jco.18.00400"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002197"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1200\/jco.1997.15.5.1745"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-12-4434"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2008.21.3991"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(15)00169-2"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2011.08942.x"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-07-0456"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2021.03.003"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.2147\/cmar.s267258"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2858"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2017-0037"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx289"},{"key":"ref88","first-page":"20","volume-title":"Refining the management of relapsed or refractory follicular lymphoma: case scenarios","author":"Pagel","year":"2020"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.2147\/blctt.s267569"},{"key":"ref90","first-page":"649","volume-title":"Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 study","author":"Italiano","year":"2018"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-15-0624"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2016.154377"},{"key":"ref93","first-page":"5123","volume-title":"Profile of polatuzumab vedotin in the treatment of patients with relapsed\/refractory non-Hodgkin Lymphoma: a brief report on the emerging clinical data","author":"Sawalha","year":"2020"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1807315"}],"container-title":["Journal of Pathology and Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jpatholtm.org\/upload\/pdf\/jptm-2021-09-29.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jpatholtm.org\/journal\/view.php?doi=10.4132\/jptm.2021.09.29","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jpatholtm.org\/upload\/pdf\/jptm-2021-09-29.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T23:06:11Z","timestamp":1641337571000},"score":1,"resource":{"primary":{"URL":"http:\/\/jpatholtm.org\/journal\/view.php?doi=10.4132\/jptm.2021.09.29"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,15]]},"references-count":94,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"URL":"https:\/\/doi.org\/10.4132\/jptm.2021.09.29","relation":{},"ISSN":["2383-7837","2383-7845"],"issn-type":[{"value":"2383-7837","type":"print"},{"value":"2383-7845","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,15]]},"assertion":[{"value":"2021-09-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-29","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-27","order":2,"name":"published","label":"Published online","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-15","order":3,"name":"published","label":"Print publication","group":{"name":"publication_history","label":"Publication History"}}]}}